Medscape6d
Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
Secondary endpoints of efficacy (patient and physician global assessments and a quality of life assessment) also supported the use of ipratropium bromide nasal spray for rhinitis symptom control.
Monthly Prescribing Reference3y
Ipratropium Nasal Spray 0.03%
Ipratropium bromide 0.03% (21mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. Epistaxis, pharyngitis, nasal dryness ...
Drug Store News18d
Lupin receives FDA nod for generic Atrovent
Lupin has received approval from the Food and Drug Administration for ipratropium bromide nasal solution (nasal spray), 0.06%, which is a generic of Boehringer Ingelheim's Atrovent Nasal Spray, 0.06%.
Pharmabiz26d
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%
Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...
moneycontrol.com12d
Lupin gets USFDA approval for nasal spray; share price trade lower
The USFDA approved company’s Abbreviated New Drug Application (ANDA) for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% (21 ... Bromide Nasal Solution id use for the symptomatic relief ...
Monthly Prescribing Reference3y
Ipratropium Nasal Spray 0.06%
Ipratropium bromide 0.06% (42mcg/spray); aqueous soln ... secretions from the serous and seromucous glands lining the nasal mucosa when applied locally. <5yrs: not recommended.